January 25, 2019 11:12 AM EST

AbbVie shares slide on sliding Humira revenue; Deerfield is making a big investment in new device startups

Shehla Shakoor

Managing Director

→ AbbVie triggered alarm bells on Wall Street today as the pharma company cited biosimilar competition in Europe for a steep decline in expected …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AbbVie shares slide on sliding Humira revenue; Deerfield is making a big investment in new device startups

Shehla Shakoor

Managing Director

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Biotech seed rounds sink to lowest level in years as industry slump drags on

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

US drugs rely heavily on ingredients made overseas, new report shows

Pharma's wins and losses in Trump's sprawling executive order on drug prices

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Ab­b­Vie shares slide on slid­ing Hu­mi­ra rev­enue; Deer­field is mak­ing a big in­vest­ment in new de­vice star­tups

Managing Director

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

AbbVie shares slide on sliding Humira revenue; Deerfield is making a big investment in new device startups